, Volume 75, Issue 4, pp 440-442

Imatinib Mesylate (Gleevec) in the Treatment of 2 Patients with Philadelphia-Positive ALL Relapsing after Allogeneic Stem Cell Transplantation

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access